CURV vs FLAC
Comparison between Torrid Holdings Inc (CURV, Company) and Frazier Lifesciences Acquisition Corp - Class A (FLAC, Company).
CURV vs FLAC - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
CURV
$175M
Winner
FLAC
$175M
Max Drawdown
CURV
96.90%
Winner
FLAC
13.15%
Sharpe Ratio
CURV
-0.54
Winner
FLAC
-0.23
5Y Beta
CURV
0.90
FLAC
N/A
Industry
CURV
Apparel Retail
FLAC
N/A
P/E Ratio
CURV
-23.75
Winner
FLAC
-36.11
Forward P/E
CURV
1.92
FLAC
N/A
Debt to Equity
Winner
CURV
-127.65%
FLAC
0.00%
Free Cash Flow Yield
CURV
-12.51%
Winner
FLAC
-0.12%
P/S Ratio
CURV
0.18
FLAC
N/A
P/B Ratio
CURV
N/A
FLAC
-15.02
CURV vs FLAC - Historical Returns
Returns include dividend reinvestment.
1M
Winner
CURV
+32.67%
FLAC
-1.40%
3M
Winner
CURV
+59.20%
FLAC
-0.70%
6M
Winner
CURV
+93.20%
FLAC
+0.41%
1Y
CURV
-59.80%
Winner
FLAC
+0.61%
5Y(CAGR)
CURV
-39.62%
FLAC
N/A
Max(CAGR)
CURV
-39.62%
Winner
FLAC
-4.92%
CURV vs FLAC - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | CURV | FLAC |
|---|---|---|
| 2026 | +87.74% | N/A |
| 2025 | -81.47% | N/A |
| 2024 | -12.98% | N/A |
| 2023 | +92.33% | N/A |
| 2022 | -71.04% | +0.71% |
| 2021 | -59.09% | -9.72% |
CURV vs FLAC Drawdown Comparison
The maximum drawdown for CURV was -96.90%, occurring on Dec 15, 2025. This drawdown has not yet recovered.
The maximum drawdown for FLAC was -13.15%, occurring on Nov 9, 2022. This drawdown has not yet recovered.
The current CURV drawdown is -93.61%. The current FLAC drawdown is -8.61%.
| Rank | CURV | FLAC |
|---|---|---|
| #1 | -96.90% Aug 24, 2021 - Dec 15, 2025 | -13.15% Feb 8, 2021 - Nov 9, 2022 |
| #2 | -16.74% Jul 6, 2021 - Aug 6, 2021 | N/A |
| #3 | -8.88% Aug 16, 2021 - Aug 24, 2021 | N/A |
| #4 | -1.36% Aug 11, 2021 - Aug 16, 2021 | N/A |
Correlation
Correlation between CURV and FLAC is -0.82 which considered as a strong negative correlation - the stocks tend to move in opposite directions.
-0.82
-101
Select Stocks to Compare
Popular: CURV vs SPYFLAC vs SPY
More Comparisons
Compare with similar stocks